L&K Biomed Ltd. (KOSDAQ:156100)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,730
-910 (-6.22%)
At close: Feb 6, 2026

L&K Biomed Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
4,8033,8355,0477,39516,1084,910
Short-Term Investments
5,60816,1087,7295,6083,1083,306
Cash & Short-Term Investments
10,41119,94312,77613,00319,2168,216
Cash Growth
-48.35%56.10%-1.75%-32.33%133.88%68.81%
Accounts Receivable
16,96314,9809,8395,7801,5263,084
Other Receivables
682.27290.261,066223.05635.92203.53
Receivables
17,92616,01510,9056,0032,1623,309
Inventory
30,36324,55119,08916,36613,85619,358
Prepaid Expenses
718.56525.95656.55444.63688.1310.2
Other Current Assets
1,0332,532990.85330.622,042851.06
Total Current Assets
60,45263,56644,41736,14737,96432,044
Property, Plant & Equipment
9,80010,0059,0128,5149,2717,890
Long-Term Investments
592.08577.51,04964.151,2031,755
Goodwill
-----244.11
Other Intangible Assets
1,051998.17798.73715.111,209836.23
Long-Term Accounts Receivable
3,6981,8071,2812,3855,2005,006
Long-Term Deferred Tax Assets
5,2285,0095,5163,9023,5918,515
Long-Term Deferred Charges
---106.09223.63427.86
Other Long-Term Assets
1,374798.55387.38829.96623.292,278
Total Assets
82,19683,06162,76252,66359,28558,995
Accounts Payable
2,7073,3472,0472,437498.731,384
Accrued Expenses
836.35851.44685.87589.86606.95791.83
Short-Term Debt
18,23020,55810,04020,4066,69212,434
Current Portion of Long-Term Debt
8008001002,800-3,128
Current Portion of Leases
730.43669.07828.69750.57636.63572.79
Current Income Taxes Payable
1.897.290.3554.090.893.59
Other Current Liabilities
9,20412,8419,06210,9434,1771,350
Total Current Liabilities
32,50939,07422,76337,98112,61319,664
Long-Term Debt
1,0001,0001,700-13,6082,100
Long-Term Leases
1,453369.63845.161,2441,5181,751
Pension & Post-Retirement Benefits
3,2103,0572,2321,5741,3301,263
Long-Term Deferred Tax Liabilities
1,2691,5691,3611,047--
Other Long-Term Liabilities
117.171,9583,27455.375,42954.28
Total Liabilities
39,55747,02832,17541,90234,49924,832
Common Stock
10,3789,9689,9686,7036,6966,635
Additional Paid-In Capital
61,04690,38690,38668,17467,99263,616
Retained Earnings
-25,274-58,746-67,849-65,348-51,884-40,051
Treasury Stock
-0.09-0.09-0.09-0.09-0.09-0.09
Comprehensive Income & Other
2,562887.932,8462,7401,6631,415
Total Common Equity
48,71142,49635,35112,26824,46731,615
Minority Interest
-6,072-6,463-4,764-1,507319.822,548
Shareholders' Equity
42,63936,03330,58710,76224,78734,163
Total Liabilities & Equity
82,19683,06162,76252,66359,28558,995
Total Debt
22,21323,39713,51325,20122,45619,986
Net Cash (Debt)
-11,801-3,454-737.76-12,198-3,240-11,770
Net Cash Per Share
-546.60-160.55-45.50-910.57-242.05-989.82
Filing Date Shares Outstanding
20.7619.9419.9413.4113.3913.24
Total Common Shares Outstanding
20.7619.9419.9413.4113.3913.27
Working Capital
27,94424,49221,654-1,83425,35112,380
Book Value Per Share
2346.932131.561773.17915.171826.892382.37
Tangible Book Value
47,66141,49834,55311,55323,25830,534
Tangible Book Value Per Share
2296.302081.501733.11861.821736.612300.96
Land
737.02737.02737.02737.02737.021,079
Buildings
2,5022,5022,5022,5022,5023,682
Machinery
17,29116,49114,30712,33011,6715,884
Construction In Progress
8459---225.65
Source: S&P Global Market Intelligence. Standard template. Financial Sources.